Sofosbuvir in Treatment of COVID 19
Last updated on July 2021Recruitment
- Recruitment Status
- Recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- COVID
- Type
- Interventional
- Phase
- Phase 2Phase 3
- Design
- Allocation: RandomizedIntervention Model: Parallel AssignmentMasking: None (Open Label)Primary Purpose: Treatment
Participation Requirements
- Age
- Younger than 125 years
- Gender
- Both males and females
Description
Sofosbuvir containing treatment of COVID 19 Egyptian patients: a randomized-controlled trial
Sofosbuvir containing treatment of COVID 19 Egyptian patients: a randomized-controlled trial
Tracking Information
- NCT #
- NCT04460443
- Collaborators
- Not Provided
- Investigators
- Principal Investigator: Marwa Salama, Consultant Tanta University - Faculty of Medicine
Get Well Soon